4.1 Article

Adult multisystem inflammatory syndrome in a patient who recovered from COVID-19 postvaccination

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Infectious Diseases

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

Shengli Xia et al.

Summary: The inactivated SARS-CoV-2 vaccine, BBIBP-CorV, demonstrated safety and immunogenicity in two age groups. Humoral responses against SARS-CoV-2 were induced in all vaccine recipients by day 42. A two-dose immunisation with 4 mu g vaccine on days 0 and 21 or days 0 and 28 achieved higher neutralising antibody titres compared to other dosing schedules.

LANCET INFECTIOUS DISEASES (2021)

Editorial Material Multidisciplinary Sciences

Rapid COVID-19 vaccine development

Barney S. Graham

SCIENCE (2020)

Article Multidisciplinary Sciences

Development of an inactivated vaccine candidate for SARS-CoV-2

Qiang Gao et al.

SCIENCE (2020)

Editorial Material Cardiac & Cardiovascular Systems

Cardiogenic Shock and Hyperinflammatory Syndrome in Young Males With COVID-19

Vinh Q. Chau et al.

CIRCULATION-HEART FAILURE (2020)

Review Immunology

Vaccines for COVID-19

J. S. Tregoning et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)

Article Public, Environmental & Occupational Health

Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection - United Kingdom and United States, March-August 2020

Sapna Bamrah Morris et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)